Eloxx Pharmaceuticals, Inc. (ELOX) — Financial Flexibility Index
Eloxx Pharmaceuticals, Inc. (ELOX) has a Financial Flexibility Index of -0.28x as of June 2026. Free cash flow of $-4.79 Million (operating CF $-4.79 Million minus capex $0.00) represents 0% of total liabilities ($16.97 Million). Check ELOX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eloxx Pharmaceuticals, Inc. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Eloxx Pharmaceuticals, Inc. across 4 annual periods. For the full cash flow conversion analysis, see Eloxx Pharmaceuticals, Inc. (ELOX) cash flow conversion.
Annual Financial Flexibility Index for Eloxx Pharmaceuticals, Inc. (2022–2025)
Year-by-year free cash flow to debt coverage for Eloxx Pharmaceuticals, Inc.. Explore ELOX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $-6.33 Million | $17.18 Million | ▲ +100.0% |
| 2024 | -0.17x | $-4.71 Million | $-4.71 Million | $27.31 Million | ▲ +70.7% |
| 2023 | -0.59x | $-14.34 Million | $-14.34 Million | $24.31 Million | ▲ +41.0% |
| 2022 | -1.00x | $-31.78 Million | $-31.84 Million | $31.78 Million | — |